Literature DB >> 19361967

Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.

E Velkoska1, F J Warner, T J Cole, I Smith, M J Morris.   

Abstract

BACKGROUND AND AIMS: Given the recent observation of a local renin-angiotensin system (RAS) in adipose tissue, and its association with obesity-related hypertension, the metabolic effects of treatment with a low dose angiotensin converting enzyme inhibitor (ACEI) were investigated in a rodent model of diet-induced obesity. METHODS AND
RESULTS: Male Sprague Dawley rats were exposed to either standard laboratory chow (12% calories as fat) or palatable high fat (30% calories as fat) diet for 12 weeks. A subset from both dietary groups was given low dose ACEI in drinking water (perindopril, 0.3 mg/kg/day) throughout the study. The high fat diet increased body weight, adiposity, circulating leptin and insulin and in the liver we observed fat accumulation and increased tissue ACE activity. Treatment with perindopril decreased food intake and circulating insulin in both diet groups, and hepatic ACE activity in high fat fed animals only. Decreased plasma leptin concentration with ACE inhibition was only evident in chow fed animals. These effects were independent of any blood pressure lowering effect of ACE inhibition.
CONCLUSION: Chronic low dose ACEI treatment reduced circulating insulin and leptin levels with some reduction in food intake in chow fed rats. Fewer beneficial effects were observed in obesity, and further work is required to investigate higher ACEI doses. Our data suggest a reduction in hepatic ACE activity may affect lipid accumulation and other inflammatory responses, as well as improving insulin resistance. Our findings may have implications for maximizing the clinical benefit of ACEI in patients without overt cardiovascular complications. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361967     DOI: 10.1016/j.numecd.2009.02.004

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  7 in total

1.  The renin, angiotensin, aldosterone, and obesity connection.

Authors:  Friedrich Luft
Journal:  J Mol Med (Berl)       Date:  2010-09       Impact factor: 4.599

2.  Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.

Authors:  Anja Miesel; Helge Müller-Fielitz; Olaf Jöhren; Florian M Vogt; Walter Raasch
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  The renin angiotensin system and the metabolic syndrome.

Authors:  Chih-Hong Wang; Feng Li; Nobuyuki Takahashi
Journal:  Open Hypertens J       Date:  2010

Review 4.  Brain renin-angiotensin system in the nexus of hypertension and aging.

Authors:  Amy C Arnold; Patricia E Gallagher; Debra I Diz
Journal:  Hypertens Res       Date:  2012-10-18       Impact factor: 3.872

5.  Dietary weight loss-induced changes in RBP4, FFA, and ACE predict weight regain in people with overweight and obesity.

Authors:  Roel G Vink; Nadia J Roumans; Edwin C Mariman; Marleen A van Baak
Journal:  Physiol Rep       Date:  2017-11

6.  Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats.

Authors:  Saad Abdulrahman Hussain; Rabab Mohammed Utba; Ajwad Muhammad Assumaidaee
Journal:  Med Arch       Date:  2017-08

7.  Lemon Extract Reduces Angiotensin Converting Enzyme (ACE) Expression and Activity and Increases Insulin Sensitivity and Lipolysis in Mouse Adipocytes.

Authors:  Shilpa Tejpal; Alan M Wemyss; Claire C Bastie; Judith Klein-Seetharaman
Journal:  Nutrients       Date:  2020-08-06       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.